This session will deliver a data-driven look at substance use trends and the evolving role of drug testing in workplace health and safety. Attendees will learn how rising positivity rates affect workforce risk, explore emerging tools such as oral fluid testing and digital solutions, and understand how drug testing can serve as a proactive health intervention rather than a punitive measure.
The drug testing industry is at a critical inflection point. Workforce shortages, changing substance use patterns and new federal regulations demand a shift from traditional punitive models to approaches that prioritize safety, compliance and recovery. Understanding current trends and innovative testing approaches – such as oral fluid testing and digitally enabled solutions – equips employers, program administrators and service providers to make informed decisions that protect both employees and organizational performance.
Audience Takeaways/Learning Points:
- Current trends: Gain insight into national substance positivity rates and their implications for workplace safety and productivity.
- Testing innovations: Learn how oral fluid testing and technology-driven processes offer practical advantages for detection, privacy and donor experience, as well as how it fits into modern workplace programs.
- Strategic application: Understand how drug testing can be positioned as a health-focused intervention tool to support recovery and reduce risk, rather than solely as a disciplinary measure.
By attending this webinar, you may be eligible to earn recertification points. Contact the Board of Certified Safety Professionals for more information.
Speakers
Mark Villoria, senior manager of scientific affairs, Abbott
With more than 20 years in clinical and analytical sciences, Mark focuses on advancing accuracy, reliability and innovation in toxicology. In his role at Abbott, he drives assay strategy, supports global product launches, develops scientific content and partners across functions to deliver evidence-based solutions. Since joining the company in 2009, he’s led major laboratory operations and progressed into roles that blend scientific expertise with strategic influence. His work, including contributions to opioid testing, earned the Abbott President’s Award. Mark earned his Ph.D. in analytical chemistry from the University of Florida and maintains his Clinical Laboratory Technologist license in Florida.
The views of webinar speakers and organizations are their own and do not necessarily reflect those of the National Safety Council or Safety+Health magazine. Any mention of a commercial enterprise, product or publication does not mean the council or magazine endorses those items.
Moderator
Barry Bottino, Associate Editor, Safety+Health magazine
Barry is associate editor of Safety+Health and serves as co-host of the magazine’s “On the Safe Side” podcast.
